In RA Treatment, Don't Overlook Underlying CV Risks In RA Treatment, Don't Overlook Underlying CV Risks

Disease-modifying antirheumatic drugs can reduce some cardiovascular risk in patients with rheumatoid arthritis, but questions remain if that's enough when statin use lags.Medscape Medical News (Source: Medscape Cardiology Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. 100% free.

Read More